Table 3.
COVID-19 patients developing AKI or not: univariate analysis (admission).
| Patients, n | AKI (n = 119) |
No AKI (n = 268) |
p |
|---|---|---|---|
| Age, years | 73.0 ± 14.9 | 62.2 ± 15.8 | 0.0001 |
| Males, n | 79 (66.4%) | 168 (62.7%) | NS |
| Systolic BP, mmHg | 125.3 ± 21 | 132.3 ± 18 | 0.04 |
| Diastolic BP, mmHg | 69.7 ± 16.2 | 76.7 ± 11.3 | 0.001 |
| Heart rate, bpm | 86.9 ± 20 | 88.5 ± 15.3 | NS |
| Positive medical history: | |||
| Arterial hypertension, n | 73 (61.3%) | 101 (41%) | 0.0001 |
| Cardiomiopathy, n | 39 (32.7%) | 59 (22%) | 0.02 |
| Chronic kidney insufficiency, n | 22 (18.5%) | 18 (6.7%) | 0.0001 |
| COPD, n | 12 (10%) | 26 (9.7%) | NS |
| Diabetes mellitus, n | 25 (21%) | 40 (14.9%) | NS |
| Malignancy, n | 20 (16.8%) | 33 (12.3%) | NS |
| Peripheral arterial disease, n | 27 (22.7%) | 23 (8.6%) | 0.0001 |
| Biochemistries at admission: | |||
| Creatinine, mg/dL | 1.82 ± 0.98 | 1.49 ± 8.8 | NS |
| Azotemia, mg/dL | 80.1 ± 57.2 | 38.8 ± 28.1 | 0.001 |
| Oxigen delivery at admission: | |||
| Low flow (Nasal cannulas/masks) | 64 (53.8%) | 138 (51.5%) | NS |
| High flow (C-PAP/HFNC) | 69 (57.9%) | 123 (45.9%) | 0.01 |
| Mechanical ventilation | 22 (18.5%) | 50 (18.9%) | NS |
| Medical therapy at admission: | |||
| ACEIs, n | 22 (18.5%) | 25 (9.4%) | 0.01 |
| ARBs, n | 16 (13.4%) | 23 (8.6%) | NS |
| At admission: | |||
| PaO2/FiO2 | 237.0 ± 107.1 | 286.2 ± 100 | 0.001 |
| Body temperature, degree | 37.3 ± 4.7 | 37.9 ± 7.5 | NS |